The open lab which is based at GSK’s Diseases of the Developing World (DDW) R&D facility in Tres Cantos, Spain provides opportunities for visiting scientists from universities, not-for-profit partnerships and other research institutes to come to the site, work on their own projects with GSK, learn from our expertise and share our world-class facilities. The open lab is part of GSK’s broader open innovation strategy in diseases of the developing world which aims to break down some of the barriers to collaboration and stimulate research within this area.
The funding for visiting scientists within the open lab is provided by an independent foundation – the Tres Cantos Open Lab Foundation (www.openlabfoundation.org) – which has a governing board comprising experts in the field of neglected tropical diseases. This board has responsibility for advising on the strategy, direction and quality of scientific research of the open lab.
The projects in the open lab portfolio include research to identify and optimise compounds that could be tested in humans against multi drug resistant TB, four separate projects in malaria and new approaches for Leishmaniasis, Chagas Disease, Sleeping Sickness.
To date we have begun nine projects (including with Barcelona Centre for International Health Research (CRESIB), Weill Cornell Medical College in the USA, and Imperial College, London) –with seven more projects approved to start later this year.
The Tres Cantos Open Lab Foundation invites scientists, researchers, academics and institutions from around the globe to propose projects that could benefit from the funding and support the Foundation can offer. The governing board will assess each proposal on its scientific merit and its match to the Foundation principles.
The Foundation seeks projects that demonstrate significant potential to contribute towards developing innovative new medicines for diseases of the developing world and that would benefit through the collaboration and discovery expertise available through GSK.
To be considered for support, there should be added value for the project in operating within the collaborative principles of open lab, and it must align with the strategic objectives of the Foundation: